How long after a transforaminal epidural steroid injection can a patient expect to see benefit?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: March 18, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Timeline for Benefit After Transforaminal Epidural Steroid Injections

Most patients who will respond to a transforaminal epidural steroid injection (TFESI) will experience significant pain relief within the first 24 hours, with day 4 being the critical timepoint to predict treatment success.

Immediate to Early Response (Hours to Days)

  • Within 1 hour post-injection, decreased pain scores are a significant predictor of favorable three-month outcomes 1, 2
  • By day 1 (24 hours), approximately 72.5% of eventual treatment responders will report greater than 50% pain relief 1
  • Patients reporting improvement at 1 hour have increased odds of treatment success at 3 months (odds ratio 1.015) 2

Critical Prediction Window (Day 4)

  • Day 4 is the most predictive timepoint for determining ultimate treatment success or failure 1
  • An additional 21.6% of eventual responders first report greater than 50% relief on day 4 1
  • The positive likelihood ratio at day 4 is 6.12, meaning a positive response at this timepoint strongly predicts 3-week success 1
  • The negative likelihood ratio at day 4 is 0.15, indicating that lack of response by day 4 strongly predicts treatment failure 1

Peak Effectiveness Period

  • The most effective period occurs within the first 5 months post-injection (mean 5.11 ± 3.07 months) 3
  • Sustained relief at day 7 or day 10 further increases the likelihood of positive 3-week outcomes, with positive likelihood ratios of 7.97 and 40, respectively 1
  • Only 5.9% of eventual responders first report greater than 50% relief after day 4 (occurring on days 13,16, or 22) 1

Duration of Benefit

  • Mean duration of injection effect is approximately 12.5 months (12.46 ± 7.24 months) in responders 3
  • The overall response rate to TFESI is approximately 72% at 2-year follow-up for lumbar disc herniation-induced radicular pain 3
  • There is a negative correlation between duration of pre-treatment symptoms and treatment effect duration—patients with shorter symptom duration before injection experience longer-lasting benefit 3

Short-Term Outcomes by Indication

  • For lumbar disc herniation with radiculopathy, observational studies report back pain relief for assessment periods ranging from 2 weeks to 3 months 4
  • Moderate certainty evidence shows that for chronic radicular spine pain, epidural injection of local anesthetic with steroids probably has little to no effect on pain relief compared to sham procedures 5
  • One randomized trial showed lower pain scores at 6 months for leg pain with TFESI compared to saline injection 4

Clinical Implications for Patient Counseling

  • If a patient has no improvement by day 4, they are unlikely to achieve meaningful benefit from that injection 1
  • Conversely, patients with early relief (within 24 hours) that persists through day 4 have high likelihood of sustained benefit 1
  • Among non-responders at 3 weeks, 33.3% initially reported greater than 50% relief on day 1, but this relief fell below 50% by day 4 in most cases (63.2%) 1

Important Caveats

  • The British Pain Society guidelines recommend fluoroscopic guidance as the gold standard for TFESI to ensure proper targeting 6
  • Shared decision-making should include discussion of potential complications, particularly with the transforaminal approach, including rare but serious adverse events such as spinal cord infarction, paraplegia, stroke, and cortical blindness 4, 5
  • TFESI should be part of a multimodal treatment regimen rather than standalone therapy 4

Related Questions

Should an MRI be obtained before administering a corticosteroid injection to the patient's shoulder joint?
How frequently can intra‑articular corticosteroid injections be administered safely for pain management?
When should I start an oral corticosteroid taper after receiving a steroid injection?
Can a 1‑year‑old child use an intranasal corticosteroid spray?
Can oral steroids be administered to a post‑facelift patient, and what dosage and duration are appropriate?
What does it mean that MRI shows mild diffuse posterior disc bulges at C4‑C5 and C5‑C6 mildly effacing the anterior subarachnoid space without cord or nerve root compromise, and a diminished bright T2 signal at L4‑L5 with a diffuse posterior disc bulge effacing epidural fat, flattening the thecal sac, and mildly encroaching the neural foramina?
How should cardiac auscultation be performed and what findings should be assessed?
How should I manage a 40-year-old man with persistent erectile dysfunction after discontinuing finasteride three months ago, high‑normal total testosterone, normal free testosterone, elevated sex‑hormone‑binding globulin, on sertraline, who now has new sugar cravings, increased appetite, low white‑blood‑cell count and microcytic anemia (low mean corpuscular volume)?
How should adenosine be administered (dose and technique) to a haemodynamically stable infant with narrow‑complex supraventricular tachycardia?
What should I do if my relative experiences a brief seizure while under the influence of N,N-Dimethyltryptamine (DMT)?
Should a patient maintained on Suboxone (buprenorphine/naloxone) continue receiving Suboxone while hospitalized and receiving additional pain medication?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.